Detailed Coverage

Mangalam Organics Reports Revenue Growth Amid Profit Decline and Auditor Change

Mangalam Organics Ltd has announced its financial results for the quarter ending June 30, 2026, showing an increase in revenue but a decrease in net profit on both standalone and consolidated bases. The company also approved the appointment of new statutory auditors.

What just happened

Standalone revenue for the quarter rose by 43.5% year-on-year to ₹163.09 crore. Consolidated revenue also saw a significant increase of 22.2% to ₹179.09 crore. However, standalone net profit declined by 23.1% to ₹5.32 crore, and consolidated net profit fell by 40.6% to ₹7.27 crore compared to the same period last year.

The company's Board has approved the appointment of M/s JMT & Associates as the new Statutory Auditors for a five-year term, replacing M/s NGST & Associates.

Why this matters

The divergence between revenue growth and profit decline suggests potential margin pressures for Mangalam Organics. Investors will be keen to understand the factors contributing to the falling profitability despite increased sales. The change in statutory auditors is also a key governance development to monitor.

The backstory

Mangalam Organics is involved in the manufacturing of pine chemicals, including camphor, resins, and terpene chemicals. The company has been focused on expanding its product portfolio and market reach.

What changes now

The appointment of M/s JMT & Associates as Statutory Auditors will bring a new external audit perspective to the company's financial reporting. The AGM on September 24, 2026, will formally ratify these changes and provide a platform for shareholder engagement.

Risks to watch

Margin pressure remains a key concern, as indicated by the declining net profit despite rising revenues. Investors should monitor cost management strategies and pricing power in the competitive chemical sector.

Peer comparison

(Peer comparison data not available in the filing)

Context metrics (time-bound)

Standalone Revenue: ₹163.09 crore (Jun 2026) vs ₹113.63 crore (Jun 2025).
Standalone PAT: ₹5.32 crore (Jun 2026) vs ₹6.92 crore (Jun 2025).
Consolidated Revenue: ₹179.09 crore (Jun 2026) vs ₹146.55 crore (Jun 2025).
Consolidated PAT: ₹7.27 crore (Jun 2026) vs ₹12.23 crore (Jun 2025).

What to track next

Investors should closely watch the company's future earnings calls and management commentary to understand the reasons behind the profit decline and the steps being taken to address margin pressures. The performance under the new auditors will also be a point of focus.